Antisoma PLC (ASM.L) AGM update and Interim Management Statement
11/10/2009 11:18:28 AM
More...
|
Antisoma PLC (ASM.L)'s AS1411 Gains US and EU Orphan Drug Status for Acute Myeloid Leukaemia
10/13/2009 7:09:15 AM
More...
|
Antisoma PLC (ASM.L): Annual Report and Accounts 2009
10/9/2009 8:22:55 AM
More...
|
Antisoma PLC (ASM.L) To Amend ACCEDE Phase III Study Of AS1413
10/8/2009 10:16:33 AM
More...
|
Antisoma PLC (ASM.L) to Present at the UBS Global Life Sciences Conference in New York
9/18/2009 10:30:15 AM
More...
|
Antisoma PLC (ASM.L) to present at the UBS Global Life Sciences Conference in New York
9/18/2009 10:26:03 AM
More...
|
Antisoma PLC (ASM.L) to present at the Bank of America (BAC) Merrill Lynch Global Healthcare Conference in London
9/16/2009 11:08:13 AM
More...
|
Antisoma PLC (ASM.L)'s Preliminary Results For The Year Ended 30 June 2009
9/14/2009 10:40:41 AM
More...
|
Antisoma PLC (ASM.L) to present at the Rodman & Renshaw Healthcare Conference in New York
9/3/2009 12:18:21 PM
More...
|
Antisoma PLC (ASM.L): Phase III Trial Of ASA404 In Lung Cancer Completes Patient Enrollment
9/1/2009 10:40:33 AM
More...
|
|